SCHEMBL29283271

SCHEMBL29283271

CC(C)NCCOC(C)C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CA12 O43570 3/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ APLNR P35414 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ CYP2D6 P10635 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ ARG1 P05089 1/20 0.31
▸ ARG2 P78540 1/20 0.31
▸ CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19823464 0.82 SMN1; SMN2 (0.34) TDP1KDM4EALDH1A1POLBCYP2D6
SCHEMBL19823462 0.82 SMN1; SMN2 (0.34) TDP1KDM4EALDH1A1POLBCYP2D6
SCHEMBL21877017 0.77 CA12 (0.33) TDP1CA1CA2CA7CA12
SCHEMBL30874619 0.77 NOS1 (0.35) CA1CA2CA7CA12APLNR
SCHEMBL1696184 0.76 MEN1 (0.38) CA1CA2CA7KMT2AMEN1
SCHEMBL29283258 0.75 MAOA (0.38) TDP1CA1CA2ALDH1A1CA7
SCHEMBL26888163 0.75 ALDH1A1 (0.41) CA1CA2ALDH1A1CYP2D6CYP1A2
SCHEMBL28883407 0.74 MEN1 (0.31) CA1CA2KMT2AMEN1GAA
SCHEMBL30068345 0.74 CA1 (0.35) CA1CA2ALDH1A1CA7KMT2A
SCHEMBL29283275 0.73 SLC6A5 (0.37) CA1CA2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103074-A Cytotoxic targeting chimeras for CCR2 expressing cells 葛兰素史克知识产权发展有限公司 2024-05-28 — — CN disclosed
Send feedback